Investor AB acquired Mölnlycke in 2007, and Mölnlycke is the largest wholly-owned subsidiary within Patricia Industries. As of May 2026, Mölnlycke formed a joint venture with Zhende Medical in China (majority-owned by Mölnlycke) to integrate wound care portfolios and accelerate growth in one of the world's fastest-growing wound care markets.
Cyborg Score Rationale
Mölnlycke demonstrates strong strategic execution through geographic expansion, strategic partnerships, and continuous innovation. Recent manufacturing investments and a joint venture in fast-growing markets signal confidence in growth trajectory. Leadership transitions (March 2026 CEO resignation) and CFO appointment changes warrant monitoring but appear operational.
Top Insights
In June 2026, Mölnlycke confirmed approximately EUR 40 million in combined investments in manufacturing facilities in Mikkeli, Finland and Oldham, UK to increase capacity and enhance supply chain resilience.
In 2024, Antiseptics delivered 23% organic growth and Wound Care reached over EUR 1.2 billion in sales.
Mölnlycke operates across four primary business areas: Wound Care, Operating Room Solutions, Gloves, and Antiseptics.
The company has 8,617 total employees.
Named Competitors
Avanos Medical Products — Surgical and wound care products
TIDI Products — Infection prevention and single-use surgical supplies
Urgo Medical — Wound care and skin health solutions
Lohmann & Rauscher — Wound care and medical compression products
Recent Developments
(June 2026) Board changes announced: Filippa Stenberg appointed as board member, Christian Cederholm departing
(June 2026) EUR 40 million combined manufacturing investment in Finland and UK to strengthen global wound care network
(May 2026) Joint venture formed with Zhende Medical in China to accelerate growth in Chinese wound care market
(April 2026) Andreas Johansson appointed as Interim Chief Financial Officer
(March 2026) CEO Zlatko Rihter resigned; Guillaume Joucla (CFO) appointed interim CEO
Open the full interactive Mölnlycke Health Care report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.